Awarded a fellowship in TB research and operations in USA by WHO
More than 30 years of experience
Been a part of many research works with Indian and overseas trail sponsors
Dr. Anand Jaiswal is the Senior Director of Department of Respiratory and Sleep Medicine Division In Medanta. He completed his MD from Vallabh Bhai Patel Chest Institute, Delhi in 1987 in TB & ..
Dr. Anand Jaiswal is the Senior Director of Department of Respiratory and Sleep Medicine Division In Medanta. He completed his MD from Vallabh Bhai Patel Chest Institute, Delhi in 1987 in TB & Respiratory Diseases and was awarded gold medal for overall performance for the same by Delhi University. He has more than 10 years of experience as a Senior Resident in various hospitals and is a senior scale, Grade-1 Chest Specialist. He was awarded a fellowship in TB research and operations in USA by WHO in 1996. He has been a part of many research works with Indian and overseas trail sponsors like ODA(UK), AMGEN(India), Pfizer(India),CSIR-OSDD etc. and has served as a Chairperson, Moderator and Lecturer in many globally renowned conferences.
Lung India : Comparative study of clinico-bacterio-radiological profile and treatment outcome of smokers and nonsmokers suffering from pulmonary tuberculosis, 2016 Click here for Publications Link
The British Journal Radiology : Accelerated hypofractionated radiotherapy with concomitant chemotherapy in locally advanced squamous cell carcinoma of lung: evaluation of response, survival, toxicity and quality of life from a Phase II randomized study, 2016 Click here for Publications Link
Indian Journal of Occupational & Environmental Medicine : Nonoccupational anthracofibrosis/anthracosilicosis from Ladakh in Jammu and Kashmir, India: A case series, 2015 Click here for Publications Link
BioMed Central : Proteomic analysis of HEK293 cells expressing non small cell lung carcinoma associated epidermal growth factor receptor variants reveals induction of heat shock response, 2015 Click here for Publications Link
PLOS One : Prevalence, Distribution and Functional Significance of the −237C to T Polymorphism in the IL-12Rβ2 Promoter in Indian Tuberculosis Patients, 2012 Click here for Publications Link
The User agrees and acknowledges that the User has read, understood and accepts the terms and conditions contained in the brochure provided with the Device (“Device”) with respect to its usage, operations, return / replacement and warranty policy.
The User hereby agrees and acknowledges that the Device (hardware and software) used in the provision
of services by Medanta is being provided on “as is” and “as available” basis through Alivecor India Private
Limited. Neither does Medanta endorse or promote the Device in any manner nor will Medanta be liable
for any claims, representations or warranties, whether express or implied as to the safety, reliability,
durability and performance of the device. The services once availed cannot be cancelled except in cases where the User requests to cancel the
service on the day of purchase in which case, full amount of service fees shall be refunded to the User
provided that the Device has not been unboxed. Before the expiry of service duration, the User can extend the services by availing various program
options. For the said purposes, the User can call our helpline number +91 124 4141414 or visit www.medanta.org. The extended program availed by the User shall be activated automatically on expiry of existing program of services.
In cases where the User has opted for availing the Services through rented Device, a refundable deposit
amount of ₹ 5,000 (“Deposit Amount”) shall be applicable and paid by the User. The refund of Deposit
Amount shall be subject to return of the Device in working and undamaged condition. Refund of Deposit
Amount shall be made through the same mode of payment as that of purchase in cases where the User
personally visits the Medanta for returning the Device. If the User opts to return the Device through post,
Deposit Amount shall be refunded electronically thorough NEFT or Bank transfer by Medanta within
seven (7) working days of receipt of the Device and receipt of scanned image/copy of the ‘Cancelled
Cheque’ of the User’s bank account.
Upon expiry of the services (either in terms of number of ECG or duration of the program) availed by the
User, the Device has to be returned within ten (10) days failing which the Deposit Amount shall be
forfeited. Please note that the ECG pack or Refundable Device deposit are non-transferable from one patient to